The insider buying is too small to be a standalone signal, but it reinforces the positive post-earnings sentiment. Monitor for larger insider purchases in the coming weeks to confirm conviction. The raised guidance and accelerating innovation adoption (Zenrelia, Credelio Quattro) provide fundamental support.
ELAN drugs
ELAN drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 11 $22.73entry
- T+1 · 3mo ago −2.64%α −2.89% · $22.13
- T+5 · 3mo ago +4.00%α +4.41% · $23.64
- T+20 · 2mo ago +3.61%α +4.67% · $23.55
- T+60 · 13d ago +11.35%α +11.84% · $25.31
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two Elanco insiders (Director Herendeen and CFO VanHimbergen) made open-market purchases totaling $334K in the week following a strong Q2 earnings beat-and-raise. While the dollar amount is trivial relative to Elanco's $11.1B market cap (0.003%), the timing after positive results and the CFO's participation add modest credibility to the bullish earnings signal.
Key Financial Metrics
Key Facts
- Director Paul Herendeen purchased 10,000 shares at $23.68 for $236,850 on 2026-08-07.
- CFO Robert VanHimbergen purchased 4,200 shares at $23.08 for $96,926 on 2026-08-07.
- Total open-market buying: $333,776, representing ~0.003% of Elanco's $11.1B market cap.
- Purchases occurred 2 days after Elanco reported Q2 2026 adjusted EPS of $0.34 (26.5% beat) and raised full-year guidance.
- Three other insiders received non-cash stock grants (no economic value) on the same date.
Financial Impact
Insider buying of $334K is immaterial relative to $11.1B market cap.
Risk Factors
- Insider buying amount is negligible relative to market cap, limiting signal strength.
- Only two insiders participated; broader C-suite buying would be more meaningful.
- Historical cluster signals on ELAN have been strong, but this cluster is unusually small.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ELAN-1786392963982 |
Track record
19 reports on ELAN
5 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +15.03% at T+5 after the May 19, 2026 report. 9 of 10 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $26.68 Now $26.41 −1.01% settles Feb 12
- Nov 12, 20264d ago SC 13G/A Neutral 2/10 Entry $26.78 Now $26.41 −1.38% settles Feb 11
- Nov 6, 202610d ago 8-K Bullish 6/10 Entry $25.74 Now $26.41 +2.60% settles Feb 4
- Nov 5, 202611d ago SC 13G/A Neutral 3/10 Entry $23.68 Now $26.41 +11.53% settles Feb 3
- Nov 3, 202613d ago 3 Neutral 1/10 Entry $25.31 Now $26.41 +4.35% settles Feb 2
- Oct 14, 20264w ago Institutional Cluster Bullish 4/10 Entry $23.54 Now $26.41 +12.19% settles Jan 12
- Sep 11, 20269w ago Press Release Neutral 1/10 Entry $23.17 Now $26.41 +13.98% settles Dec 7
- Aug 21, 202612w ago Insider Cluster Bullish 6/10 Entry $24.42 Now $26.41 +8.15% settles Nov 17
- Aug 21, 202612w ago Insider Cluster Bullish 4/10 Entry $24.42 Now $26.41 +8.15% settles Nov 17
- Aug 18, 202612w ago Insider Cluster Bullish 4/10 Entry $24.50 to $26.50 Now $26.41 +7.80% ▲ +8.16% +9.72% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers